Elan (ELN) Will Be a Buyer Not a Seller, Unless Offer Nears $20/Sh - Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St advances on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices sink, shrugging off renewed Middle East fighting
- ASML capacity upgrade soothes AI chip bottleneck fears
Leerink Swann Upgrades Elan Corp (ELN) to Market Perform
February 25, 2013 9:20 AM ESTLeerink Swann upgraded Elan Corp (NYSE: ELN) from Underperform to Market Perform.
For an analyst ratings summary and ratings history on Elan Corp click here. For more ratings news on Elan Corp click here.
Shares of Elan Corp closed at $10.60 yesterday, with a 52 week range of $9.37-$15.27.... More
Elan Corp (ELN) Up 9% on Takeover Bid
February 25, 2013 6:55 AM ESTElan Corp (NYSE: ELN) is trading up 9 percent to $11.60/share early Monday after receiving an $11/share takeover bid from Royalty Pharma.... More
RP Management Bids $11/Share for Elan Corp (ELN)
February 25, 2013 6:06 AM ESTRP Management, LLC ("Royalty Pharma") today announces that contact was made on Monday February 18, 2013 with the Chairman of the Board of Elan Corporation, plc (NYSE: ELN) ("Elan"), followed by a meeting then taking place on Wednesday February 20, 2013, at which an indicative proposal was made to acquire the entire issued and to be issued share capital of Elan (the "Proposal").
Royalty Pharma is proposing, on an indicative basis, to make an offer for Elan (the "Possible Offer") of US$11[1] for every Elan Share and every Elan ADS.
While Royalty... More
